Elevated labile Cu is associated with oxidative pathology in Alzheimer disease

被引:142
|
作者
James, Simon A. [1 ,2 ,3 ]
Volitakis, Irene [1 ]
Adlard, Paul A. [1 ]
Duce, James A. [1 ]
Masters, Colin L. [1 ]
Cherny, Robert A. [1 ]
Bush, Ashley I. [1 ,4 ]
机构
[1] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia
[2] CSIRO Mat Sci & Engn, Clayton, Vic 3168, Australia
[3] CSIRO Prevent Hlth Flagship, Clayton, Vic 3168, Australia
[4] Univ Melbourne, Dept Pathol, Melbourne, Vic 3052, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
Alzheimer disease; Copper; Oxidative stress; Cortex; Metal homeostasis; Free radicals; MILD COGNITIVE IMPAIRMENT; TRANSGENIC MICE; AMYLOID-BETA; A-BETA; COPPER; METALS; BRAIN; TOXICITY; STRESS; DAMAGE;
D O I
10.1016/j.freeradbiomed.2011.10.446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress is implicated in Alzheimer disease (AD) pathogenesis, for which evidence indicates that radical species are generated by the redox-active biometal Cu. The contribution of labile Cu to the oxidative stress observed in AD has not been evaluated. The Cu content of postmortem cortical tissue from nondemented elderly controls and AD cases was measured using inductively coupled plasma mass spectroscopy, and the proportion of labile Cu was assessed using the Cu-phenanthroline assay. Further, the capacity of the tissue to stabilize Cu(2+) was evaluated using immobilized metal-affinity chromatography, and the level of tissue oxidative damage was determined by the presence of thiobarbituric acid-reactive compounds. We identified elevated levels of exchangeable Cu(2+), which were correlated with tissue oxidative damage; additionally, we noted an increased capacity of AD cortical tissue samples to bind Cu(2+). This deranged Cu homeostasis reflects the homeostatic breakdown of Cu observed in AD and supports biometal metabolism as a therapeutic target. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:298 / 302
页数:5
相关论文
共 50 条
  • [41] Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
    Matsubara, E
    Bryant-Thomas, T
    Quinto, JP
    Henry, TL
    Poeggeler, B
    Herbert, D
    Cruz-Sanchez, F
    Chyan, YJ
    Smith, MA
    Perry, G
    Shoji, M
    Abe, K
    Leone, A
    Grundke-Ikbal, I
    Wilson, GL
    Ghiso, J
    Williams, C
    Refolo, LM
    Pappolla, MA
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 (05) : 1101 - 1108
  • [42] Oxidative stress in Alzheimer disease
    Gella, Alejandro
    Durany, Nuria
    CELL ADHESION & MIGRATION, 2009, 3 (01) : 88 - 93
  • [43] Oxidative stress and Alzheimer disease
    Christen, Y
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 71 (02): : 621S - 629S
  • [44] Oxidative imbalance in Alzheimer disease
    Zhu, XW
    Nunomura, A
    Takeda, A
    Lee, HG
    Casadesus, G
    Perry, G
    Smith, MA
    FREE RADICAL RESEARCH, 2005, 39 : S31 - S31
  • [45] Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease
    Yavuz, Burcu Balam
    Yavuz, Bunyamin
    Halil, Meltem
    Cankurtaran, Mustafa
    Ulger, Zekeriya
    Cankurtaran, Eylem Sahin
    Aytemir, Kudret
    Ariogul, Serviet
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (04) : 815 - 823
  • [46] Spreading of Pathology in Alzheimer's Disease
    Lv, Zhong-Yue
    Tan, Chen-Chen
    Yu, Jin-Tai
    Tan, Lan
    NEUROTOXICITY RESEARCH, 2017, 32 (04) : 707 - 722
  • [47] Cerebrovascular pathology and Alzheimer's disease
    Nelson, Peter T.
    LANCET NEUROLOGY, 2016, 15 (09): : 895 - 896
  • [48] Molecular pathology of Alzheimer's disease
    Yamazaki, T
    Ihara, Y
    NEUROPATHOLOGY, 1997, 17 (04) : 263 - 269
  • [49] Vascular pathology in Alzheimer's disease
    Hulette, C
    Ervin, J
    Broom, L
    Szymanski, M
    Schmechel, D
    Corder, E
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S486 - S486
  • [50] Olfactory pathology in aging and Alzheimer disease
    Attems, J
    Jellinger, KA
    Lintner, F
    ACTA NEUROPATHOLOGICA, 2005, 110 (03) : 321 - 321